1. Home
  2. WLTH vs PGEN Comparison

WLTH vs PGEN Comparison

Compare WLTH & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

WLTH

Wealthfront Corporation Common Stock

N/A

Current Price

$9.25

Market Cap

1.7B

Sector

Finance

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$5.29

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WLTH
PGEN
Founded
2008
1998
Country
United States
United States
Employees
391
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
WLTH
PGEN
Price
$9.25
$5.29
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$12.86
$8.33
AVG Volume (30 Days)
2.1M
5.7M
Earning Date
05-18-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$10.58
$1,115.92
Revenue Next Year
$23.43
$81.04
P/E Ratio
$10.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.20
$1.47
52 Week High
$14.12
$6.04

Technical Indicators

Market Signals
Indicator
WLTH
PGEN
Relative Strength Index (RSI) 48.03 54.67
Support Level $7.93 $5.20
Resistance Level $9.32 $5.47
Average True Range (ATR) 0.47 0.36
MACD 0.16 -0.04
Stochastic Oscillator 75.92 34.35

Price Performance

Historical Comparison
WLTH
PGEN

About WLTH Wealthfront Corporation Common Stock

Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: